These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 28844443)
1. Prognostic markers in HIV mono-and co-infected individuals: A study from Karachi-Pakistan. Shaukat SN; Khan S; Raza A; Khanani R; Ghayaz A; Kazmi SU J Infect Public Health; 2018; 11(2):250-254. PubMed ID: 28844443 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study. Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842 [TBL] [Abstract][Full Text] [Related]
3. Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy. Musyoki AM; Msibi TL; Motswaledi MH; Selabe SG; Monokoane TS; Mphahlele MJ J Med Virol; 2015 Feb; 87(2):213-21. PubMed ID: 25156907 [TBL] [Abstract][Full Text] [Related]
4. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia. Al-Mughales JA J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function. Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670 [TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii, HBV, and HCV co-infection and their correlation with CD4 cells among Iranian HIV-positive patients. Bazmjoo A; Bagherzadeh MA; Raoofi R; Taghipour A; Mazaherifar S; Sotoodeh H; Ostadi Z; Shadmand E; Jahromi MAM; Abdoli A Immun Inflamm Dis; 2023 Feb; 11(2):e794. PubMed ID: 36840494 [TBL] [Abstract][Full Text] [Related]
7. [A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status]. Long L; Liu Y; Duan Z; Xu Q; Shen T; Dou X; Zhuang H; Lu F Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):244-50. PubMed ID: 25173220 [TBL] [Abstract][Full Text] [Related]
8. The APOBEC3B deletion polymorphism is associated with prevalence of hepatitis B virus, hepatitis C virus, Torque Teno virus, and Toxoplasma gondii co-infection among HIV-infected individuals. Prasetyo AA; Sariyatun R; Reviono ; Sari Y; Hudiyono ; Haryati S; Adnan ZA; Hartono ; Kageyama S J Clin Virol; 2015 Sep; 70():67-71. PubMed ID: 26305823 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola. Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697 [TBL] [Abstract][Full Text] [Related]
10. Molecular surveillance of HCV mono-infection and HCV-HBV co-infection in symptomatic population at Hyderabad, Pakistan. Patoli BB; Patoli AA; Balani NK; Korejo AA Afr Health Sci; 2018 Sep; 18(3):531-538. PubMed ID: 30602984 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China. Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454 [TBL] [Abstract][Full Text] [Related]
12. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients. Anggorowati N; Yano Y; Heriyanto DS; Rinonce HT; Utsumi T; Mulya DP; Subronto YW; Hayashi Y J Med Virol; 2012 Jun; 84(6):857-65. PubMed ID: 22499006 [TBL] [Abstract][Full Text] [Related]
13. Impact of HBV and HCV coinfection on CD4 cells among HIV-infected patients: a longitudinal retrospective study. Silva CMD; Peder LD; Silva ES; Previdelli I; Pereira OCN; Teixeira JJV; Bertolini DA J Infect Dev Ctries; 2018 Nov; 12(11):1009-1018. PubMed ID: 32012132 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana. Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533 [TBL] [Abstract][Full Text] [Related]
15. Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China. Huang SM; Cai WP; Hu FY; Lan Y; Liao BL; Chen YP; Tang XP Int J STD AIDS; 2016 Sep; 27(10):890-7. PubMed ID: 26384940 [TBL] [Abstract][Full Text] [Related]
16. Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal. Shrestha LB; Yadav GK; Pradhan S; Sharma A; Pandit T; Chhetry R; Khanal B PLoS One; 2022; 17(3):e0264791. PubMed ID: 35239716 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade. Noubiap JJ; Aka PV; Nanfack AJ; Agyingi LA; Ngai JN; Nyambi PN PLoS One; 2015; 10(9):e0137375. PubMed ID: 26371878 [TBL] [Abstract][Full Text] [Related]
18. Incidence of tuberculosis and mycobacteriosis among HIV-infected patients--clinical and epidemiological analysis of patients from north-eastern Poland. Łucejko M; Grzeszczuk A; Rogalska M; Flisiak R Pneumonol Alergol Pol; 2013; 81(6):502-10. PubMed ID: 24142779 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]